Accès libre

Association between Osteoprotegerin gene polymorphisms and risk of coronary artery disease: A systematic review and meta-analysis

, ,  et    | 29 déc. 2017
À propos de cet article

Citez

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11): e442.MathersCDLoncarD.Projections of global mortality and burden of disease from 2002 to 2030PLoS Med.2006311e44210.1371/journal.pmed.0030442Search in Google Scholar

Akesson A, Larsson SC, Discacciati A, Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: A population-based prospective cohort study. J Am Coll Cardiol. 2014; 64(13): 1299-1306.AkessonALarssonSCDiscacciatiAWolkA.Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: A population-based prospective cohort studyJ Am Coll Cardiol.201464131299130610.1016/j.jacc.2014.06.1190Search in Google Scholar

Strik JJ, Honig A, Maes M. Depression and myocardial infarction: Relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(4): 879-892.StrikJJHonigAMaesM.Depression and myocardial infarction: Relationship between heart and mindProg Neuropsychopharmacol Biol Psychiatry.200125487989210.1016/S0278-5846(01)00150-6Search in Google Scholar

Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction – 2013. Curr Cardiol Rep. 2013; 15(6): 368.KesslerTErdmannJSchunkertH.Genetics of coronary artery disease and myocardial infarction – 2013Curr Cardiol Rep.201315636810.1007/s11886-013-0368-0Search in Google Scholar

Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009; 41(3): 280-282.SamaniNJErdmannJHallASHengstenbergCManginoMMayerBNew susceptibility locus for coronary artery disease on chromosome 3q22.3Nat Genet.200941328028210.1038/ng.307Search in Google Scholar

Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015; 47(10): 1121-1130.NikpayMGoelAWonHHHallLMWillenborgCKanoniSA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery diseaseNat Genet.201547101121113010.1038/ng.3396Search in Google Scholar

Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2): 309-319.SimonetWSLaceyDLDunstanCRKelleyMChangMSLüthyROsteoprotegerin: A novel secreted protein involved in the regulation of bone densityCell.199789230931910.1016/S0092-8674(00)80209-3Search in Google Scholar

Montagnana M, Lippi G, Danese E, Guidi GC. The role of osteoprotegerin in cardiovascular disease. Ann Med. 2013; 45(3): 254-264.MontagnanaMLippiGDaneseEGuidiGC.The role of osteoprotegerin in cardiovascular diseaseAnn Med.201345325426410.3109/07853890.2012.72701923110639Search in Google Scholar

Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis. 2009; 204(2): 321-329.Van CampenhoutAGolledgeJ.Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis.2009204232132910.1016/j.atherosclerosis.2008.09.033272905219007931Search in Google Scholar

Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation. 2002; 106(10): 1192-1194.JonoSIkariYShioiAMoriKMikiTHaraKSerum osteoprotegerin levels are associated with the presence and severity of coronary artery diseaseCirculation.2002106101192119410.1161/01.CIR.0000031524.49139.2912208791Search in Google Scholar

Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab. 2003; 88(3): 1024-1028.SchoppetMSattlerAMSchaeferJRHerzumMMaischBHofbauerLC.Increased osteoprotegerin serum levels in men with coronary artery diseaseJ Clin Endocrinol Metab.20038831024102810.1210/jc.2002-02077512629080Search in Google Scholar

Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC et al. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab. 2004; 89(8): 3764-3768.SoufiMSchoppetMSattlerAMHerzumMMaischBHofbauerLCOsteoprotegerin gene polymorphisms in men with coronary artery diseaseJ Clin Endocrinol Metab.20048983764376810.1210/jc.2003-03205415292302Search in Google Scholar

Ohmori R, Momiyama Y, Taniguchi H, Tanaka N, Kato R, Nakamura H, et al. Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. Atherosclerosis. 2006; 187(1): 215-217.OhmoriRMomiyamaYTaniguchiHTanakaNKatoRNakamuraHAssociation between osteoprotegerin gene polymorphism and coronary artery disease in Japanese menAtherosclerosis.2006187121521710.1016/j.atherosclerosis.2006.03.02616678184Search in Google Scholar

Luo ZR, Xie QJ. Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue. 2012; 24(12): 730-733.LuoZRXieQJ.Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian areaZhong Guo Wei Zhong Bing Ji Jiu Yi Xue.20122412730733Search in Google Scholar

Celczyńska Bajew L, Horst Sikorska W, Bychowiec B, Wykrętowicz A, Wesoly J, Michalak M. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. Kardiol Pol. 2011; 69(6): 573-578.Celczyńska BajewLHorst SikorskaWBychowiecBWykrętowiczAWesolyJMichalakM.The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral densityKardiol Pol.2011696573578Search in Google Scholar

Hong WL, Guo XG, Jiao QP, Tan ZR, Chen Y, Qiu ZH, et al. Correlation of osteoprotegerin gene G1181C polymorphisms with presence and severity of coronary artery disease in Chinese Han people in Shanghai. Shanghai Med J. 2012; 35(5): 420-424.HongWLGuoXGJiaoQPTanZRChenYQiuZHCorrelation of osteoprotegerin gene G1181C polymorphisms with presence and severity of coronary artery disease in Chinese Han people in ShanghaiShanghai Med J.2012355420424Search in Google Scholar

Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994; 90(1): 583-612.Tunstall-PedoeHKuulasmaaKAmouyelPArveilerDRajakangasAMPajakA.Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continentsCirculation.199490158361210.1161/01.CIR.90.1.5838026046Search in Google Scholar

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603-605.StangA.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol.201025960360510.1007/s10654-010-9491-z20652370Search in Google Scholar

Guo C, Hu F, Zhang S, Wang Y, Liu H. Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients. Genet Mol Biol. 2013; 36(2): 177-182.GuoCHuFZhangSWangYLiuH.Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patientsGenet Mol Biol.201336217718210.1590/S1415-47572013005000024371528223885198Search in Google Scholar

Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol. 2010; 55(19): 2049-2061.VenurajuSMYerramasuACorderRLahiriA.Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidityJ Am Coll Cardiol.201055192049206110.1016/j.jacc.2010.03.01320447527Search in Google Scholar

Ren MY, Sui SJ, Zhang Y, Xu FY, Xu XQ, Zhao JJ, et al. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome. Acta Cardiol. 2008; 63(5): 615-622.RenMYSuiSJZhangYXuFYXuXQZhaoJJIncreased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndromeActa Cardiol.200863561562210.2143/AC.63.5.203323019014006Search in Google Scholar

eISSN:
1311-0160
Langue:
Anglais
Périodicité:
2 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other